Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Mochi Health vs Wisp

Mochi Health and Wisp sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Mochi Health logo

Mochi Health

6.6
★★★☆☆3.3/5

Best for: coaching bundled into the price rather than sold separately

Visit Mochi Health →
VS
Wisp logo

Wisp

6.5
★★★☆☆3.3/5

Best for: an oral route if you will not self-inject

Visit Wisp →

If you are choosing between Mochi Health and Wisp, price alone will not settle it. Mochi Health leads our six-part score, 6.6 to 6.5.

Mochi Health vs Wisp price

Wisp publishes $99 a month. Mochi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Wisp lists semaglutide and tirzepatide; Mochi Health does not name its drug.

On format, Mochi Health posts no priced format, while Wisp prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Wisp is the only one of the two with a brand-name price.

Where each one treats patients

Mochi Health lists 15 states, and Wisp does not publish where it ships.

Pricing

Mochi Health

Starting dose (membership $79/mo + medication)Compounded
$139/mo
semaglutide

Membership is $79/mo plus $60/mo for compounded semaglutide. The $39 membership Mochi leads with is a first-month rate for new customers; the standard rate is $79 per month after that. The $60 is a 'starting at' price that varies by dose, the lowest rung rather than a flat rate. $99 is shown struck through beside it.

Starting dose (membership $79/mo + medication)Compounded
$169/mo
tirzepatide

Membership is $79/mo plus $90/mo for compounded tirzepatide. The $39 membership is a first-month promotional rate; the standard rate is $79. The $90 is a 'starting at' price that varies by dose. $199 is shown struck through beside it.

Wisp

Compounded sublingual semaglutide drops 15mLCompounded
$225/mo
semaglutide
Metabolic Support & GLP-1 Boost capsules (adjunct supplement, not a prescription GLP-1)supplement subscription
$54/mo

Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.

StartingBrand-name
$99/mo
tirzepatide

Zepbound $99/mo (compounded sublingual semaglutide $225/mo)

What each price covers

Mochi Health's price also covers the clinician visit and coaching, which Wisp does not claim.

Wisp's price also covers the medication itself and shipping, which Mochi Health does not claim.

Mochi Health is silent on shipping and lab work.

Wisp is silent on the clinician visit, lab work and coaching.

That matters most for the drug: unless Mochi Health confirms otherwise, budget for medication on top of its listed price.

Mochi Health

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Wisp

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Mochi Health scores 6.6 and Wisp 6.5 out of 10.

Mochi Health is stronger on trust & safety (8.5 vs 6.5).

Wisp is stronger on value (3.5 vs 3.0), accessibility (5.0 vs 4.4) and support (4.5 vs 4.0).

Effectiveness and user experience are within half a point.

How we score

Mochi Health

6.6/10

Overall

Wisp

6.5/10

Value25%

3.0A
vs
B
3.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
6.5

Accessibility10%

4.4A
vs
B
5.0

Support10%

4.0A
vs
B
4.5

FDA warning letters

Neither Mochi Health nor Wisp has an FDA warning letter on record with us.

Features & Coverage

FeatureMochi HealthWisp
Starting PriceNot published$99/mo
Features3 features✓8 features
States Available15Not disclosed
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Mochi Health

Mochi Health is an obesity medicine telehealth seller running aggressively priced compounded GLP-1 programs.

Read our full Mochi Health review →

About Wisp

$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.

Read our full Wisp review →

Pros & Cons

Mochi Health

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits and coaching
  • We found no FDA warning letters issued to Mochi Health

Watch-outs

  • Not included in the monthly price: medication
  • Serves only 15 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Wisp

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and shipping
  • We found no FDA warning letters issued to Wisp

Watch-outs

  • Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Mochi Health

Mochi Health wins this one, 6.6 to 6.5, above all for coaching bundled into the price rather than sold separately. Wisp fits better if an oral route if you will not self-inject is your priority.

Choose Mochi Health if…

You want coaching bundled into the price rather than sold separately.

Choose Wisp if…

You want an oral route if you will not self-inject and an opening price near $99 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

Mochi Health vs Wisp: FAQ

Only Wisp publishes a price ($99 a month). Mochi Health quotes after sign-up.
No. Mochi Health lists no named drug; Wisp lists semaglutide and tirzepatide.
Mochi Health lists 15 states; Wisp does not publish where it ships. Confirm your state before paying.
Only Mochi Health includes the clinician visit and coaching. Only Wisp includes the medication itself and shipping.
Mochi Health has none. Wisp has none.
No. Neither Mochi Health nor Wisp pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.